Manli Wang, PhD
Specially Appointed Researcher, TCM Prevention and Treatment of Metabolic and Chronic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine.
Education
- BS, Southwest Jiaotong University (2017)
- PhD, Sichuan University (2022)
Working Experience
- Postdoc, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University. (2022-2025)
- Specially Appointed Researcher, Hospital of Chengdu University of Traditional Chinese Medicine (2026.01-present)
Selected Publications
- Wang Y#, Zhong A#, Wang B#, Zhai X, Lei C, Liang Z, Deng X, Zhong J, Xiao C, Zheng J, Wu B, Zhang L, Wang Y, Luo X, Wang J, Zhang M, Liu H, Wan X, Dai S, Yang Y, Zhang S, Wang W, Yang S, Xue J, Zhao C, Tammela T, Li Z, Zhang Y*, Na F*, Wang M*, Liu Y*, Chen C*. A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers. Cell. 2026 May 7:S0092-8674(26)00452-6. doi: 10.1016/j.cell.2026.04.017.
- Wang M#, Chen X#, Tan P#, Wang Y#, Pan X, Lin T, Jiang Y, Wang B, Xu H, Wang Y, Yang Y, Wang J, Zhao L, Zhang J, Zhong A, Peng Y, Du J, Zhang Q, Zheng J, Chen J, Dai S, Na F, Lu Z, Liu J, Zheng X, Yang L, Zhang P, Han P, Gong Q, Zhong Q, Xiao K, Yang H, Deng H, Zhao Y, Shi H, Man J, Gou M, Zhao C, Dai L, Xue Z, Chen L, Wang Y, Zeng M, Huang C, Wei Q*, Wei Y, Liu Y*, Chen C*. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell. 2022 Sep 12;40(9):1044-1059.e8.
- Wang M#, Wang Y#, Pan X#, Wang B#, Wang Y#, Luo X#, Deng X, Liu L, Chen X, Zhai X, Wu B, Zhang Q, Ren Y, Li J, Li X, Cao F, Yang Y, Deng X, Li R, Lu Z, Tan P, Chen J, Li Y, Liu Y, Liu J, Wang Y, Deng H, Su Z, Wang W, Wang Y, Yang S, Zhao C, Xue J, Wei Y, Zhang K*, Na F*, Liu Y*, Chen C*. Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer. Proc Natl Acad Sci USA. 2025 Jun 17;122(24):e2500019122.
- Tan P#, Wang M#, Zhong A, Wang Y, Du J, Wang J, Qi L, Bi Z, Zhang P, Lin T, Zhang J, Yang L, Chen J, Han P, Gong Q, Liu Y, Chen C*, Wei Q*. SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis. Oncogene. 2021 Oct;40(42):6081-6092.
- Zhai X#, Wang M#, Zhang Q#, Li D#, Wu Y, Liang Z, Liu J, Wang W, Liu Y, Che G, Zhou Q, Chen C. Identifying the Intergenic ALK Fusion LOC388942-ALK as a Driver of Non-Small Cell Lung Cancer. MedComm (2020). 2025 Mar 27;6(4):e70154.